Get access

Experimental animal model of refractoriness to donor platelets: the effect of plasma removal and the extent of white cell reduction on allogeneic alloimmunization

Authors

  • J.O. Bordin,

    1. Departments of Pathology and Medicine, McMaster University, and the Canadian Red Cross Society, Hamilton, Ontario, Canada.
    Search for more papers by this author
    • 2

      José O. Bordin, MD, Associate Professor, Escola Paulista de Medicina, São Paulo, Brazil; Visiting Scientist, Department of Pathology, McMaster University, Hamilton, ON, Canada.

  • L. Bardossy,

    1. Departments of Pathology and Medicine, McMaster University, and the Canadian Red Cross Society, Hamilton, Ontario, Canada.
    Search for more papers by this author
    • 3

      Leslie Bardossy, Research Technologist, Department of Pathology, McMaster University.

  • M.A. Blajchman

    Professor, Corresponding author
    1. Departments of Pathology and Medicine, McMaster University, and the Canadian Red Cross Society, Hamilton, Ontario, Canada.
      Departments of Medicine and Pathology, Room 2N31, McMaster University Medical Centre, 1200 Main Street West, Hamilton, ON, L8N 3Z5, Canada.
    Search for more papers by this author
    • 4

      Morris A. Blajchman, MD, Medical Director, Hamilton Centre Canadian Red Cross Society (CRCS)


Departments of Medicine and Pathology, Room 2N31, McMaster University Medical Centre, 1200 Main Street West, Hamilton, ON, L8N 3Z5, Canada.

Abstract

Platelet transfusion effectiveness may be limited in multiply transfused patients by the development of the refractory state. White cell (WBC)-reduction filters with variable efficiency (1–3 log10 reduction) are available and have been shown to be effective in reducing the incidence of platelet alloimmunization. However, the threshold number of WBCs below which alloimmunization would no longer occur is yet to be determined. A previously established animal model was used to examine the relative efficiency of second- and third- generation filters in reducing the frequency of refractoriness to allogeneic platelets. In this model, California Black rabbits are used as blood donors and New Zealand White rabbits as transfusion recipients. Eight weekly transfusions of either second-generation or third-generation WBC-reduced blood resulted in no difference between the two groups in mean platelet survival and rate of refractoriness to allogeneic platelets. To evaluate the possible incremental benefit of removing supernatant plasma to prevent platelet refractoriness, experiments were performed in which groups of animals were given transfusion(s) with red cell suspensions that had been WBC-reduced or both plasma-depleted and WBC-reduced. A significantly lower rate of allogeneic platelet refractoriness was seen in the rabbits that received WBC-reduced and plasma-depleted red cells than in those that received red cells that had been WBC-reduced only. These data provide evidence that the combined use of plasma depletion and WBC reduction can decrease still further the frequency of refractoriness produced by allogeneic blood transfusions.

Get access to the full text of this article

Ancillary